Type 2 diabetes medicines
Revise metformin, SGLT2 inhibitors, GLP-1 receptor agonists, insulin escalation, cardiovascular or renal indications, contraindications and when HbA1c targets change.
Diabetes and endocrine questions usually test safe GP thresholds: how to interpret HbA1c or thyroid function, when a medicine is unsafe during illness, which complication must be screened, and when a vague presentation is actually an endocrine emergency.
For AKT diabetes and endocrinology revision, prioritise type 2 diabetes medicines, HbA1c targets, SGLT2 inhibitor safety, urine ACR and eGFR, diabetic emergencies, thyroid function tests, sick-day rules, obesity and metabolic risk, adrenal insufficiency and calcium disorders.
Revise metformin, SGLT2 inhibitors, GLP-1 receptor agonists, insulin escalation, cardiovascular or renal indications, contraindications and when HbA1c targets change.
Know HbA1c, blood pressure, lipids, urine ACR, eGFR, foot checks, retinal screening, hypoglycaemia, DKA and hyperosmolar hyperglycaemic state.
Understand medication pauses during acute illness, dehydration risk, ketone testing, insulin safety and steroid sick-day rules in adrenal insufficiency.
Focus on TSH and free T4 interpretation, subclinical disease, levothyroxine monitoring, Graves' disease, carbimazole risks and thyroid red flags.
Revise BMI and waist-to-height assessment, ethnicity and risk, hypertension, lipids, NAFLD, sleep apnoea, weight-management medicines and bariatric referral principles.
Recognise Addison's disease, steroid emergency rules, hypercalcaemia, primary hyperparathyroidism, malignancy patterns, osteoporosis and vitamin D deficiency.
The AKT rarely asks for diabetes or thyroid facts in isolation. It usually asks what the result means for this patient: which medicine is unsafe, which complication changes the target, which symptom needs urgent action, or which monitoring step has been missed.
Yes. The RCGP metabolic and endocrinology topic includes diabetes, thyroid disease, obesity, adrenal disease, calcium disorders, biochemical test interpretation, chronic disease monitoring and endocrine emergencies.
Prioritise type 2 diabetes medicines, HbA1c targets, SGLT2 inhibitor cautions, GLP-1 receptor agonists, insulin safety, hypoglycaemia, DKA, HHS, urine ACR, eGFR, foot checks and retinal screening.
Thyroid questions often test TSH and free T4 interpretation, subclinical hypothyroidism, levothyroxine monitoring, Graves' disease, carbimazole adverse effects, pregnancy considerations and urgent thyrotoxicosis red flags.
Know when acute illness changes diabetes treatment, when to pause dehydration-risk medicines, when to check ketones, why insulin should not be stopped casually, and why adrenal insufficiency needs steroid sick-day escalation.
This is revision guidance, not official RCGP advice. Check current RCGP, NICE CKS and BNF guidance for clinical decisions. Last reviewed June 2026.
Questions, mocks and explanations are free. Your first 2 hours of AKT audio are free. Full 4-month audio access is £79.